Literature DB >> 15299922

Purification, crystallization and preliminary X-ray analysis of Bacteroides fragilis Zn2+ beta-lactamase.

A Carfí1, R Paul-Soto, L Martin, Y Pétillot, J M Frère, O Dideberg.   

Abstract

The Zn(2+) beta-lactamase from Bacteroides fragilis (E.C. 3.5.2.6) was overexpressed in Escherichia coli using an isopropylthiogalactoside-inducible T7 RNA polymerase expression system. Crystallization trials by the hanging-drop vapour-diffusion method have yielded two different crystal forms from two slightly different conditions. Crystals of form I belong to the monoclinic space group C2 with unit-cell dimensions a = 56.03, b = 43.98, c = 105.32 A, beta = 112 degrees and diffracted only up to 4.0 A. Crystals of form II are orthorhombic, space group P2(1)2(1)2(1) with unit-cell dimensions a = 48.10, b = 98.05, c = 111.76 A, diffract to at least 2.0 A and are suitable for high-resolution structural analysis.

Entities:  

Year:  1997        PMID: 15299922     DOI: 10.1107/S0907444997000966

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  3 in total

1.  The mechanism of catalysis and the inhibition of the Bacillus cereus zinc-dependent beta-lactamase.

Authors:  S Bounaga; A P Laws; M Galleni; M I Page
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

2.  The Reaction Mechanism of Metallo-β-Lactamases Is Tuned by the Conformation of an Active-Site Mobile Loop.

Authors:  Antonela R Palacios; María F Mojica; Estefanía Giannini; Magdalena A Taracila; Christopher R Bethel; Pedro M Alzari; Lisandro H Otero; Sebastián Klinke; Leticia I Llarrull; Robert A Bonomo; Alejandro J Vila
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

3.  Probing substrate binding to metallo-beta-lactamase L1 from Stenotrophomonas maltophilia by using site-directed mutagenesis.

Authors:  Anne L Carenbauer; James D Garrity; Gopal Periyannan; Robert B Yates; Michael W Crowder
Journal:  BMC Biochem       Date:  2002-02-13       Impact factor: 4.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.